Share on Facebook
Share on Twitter
Share on LinkedIn

The U.S. Food and Drug Administration is requiring a stronger warning label on a group of drugs commonly used by many Americans for anxiety, the agency announced Wednesday.

All benzodiazepine products, which include well-known drugs such as Xanax and Valium, must have warning labels that spell out the risks of abuse, misuse, addiction, physical dependence and withdrawal. The FDA has called for a “Boxed Warning,” which is the agency’s most prominent safety warning.

Learn more here.